Stay updated on Remibrutinib Long-term Extension in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Remibrutinib Long-term Extension in Urticaria Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added new study locations across multiple countries (examples include Uskudar, Melikgazi, Karsiyaka, Karabaglar, Efeler, Buca, Atakum, Adapazari, Hajdu Bihar Megye, Hesse, Bavaria, Cundinamarca, and more) and removed numerous sites; total locations updated from 207 to 208.
    Difference
    2%
    Check dated 2026-03-12T20:42:18.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2, indicating a minor UI/version change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:22:05.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-04T23:11:12.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    New UI elements include a glossary toggle and a revision label (Revision: v3.4.0); existing QC-related labels were adjusted only in capitalization (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T18:37:28.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.3.4, replacing the previous v3.3.3. This appears to be a minor, non-content change to the page.
    Difference
    0.0%
    Check dated 2026-01-14T03:45:04.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Expanded the Locations section to include numerous individual trial sites across the US, Argentina, Canada, Europe, Asia, and other regions, replacing the prior grouped location entries.
    Difference
    3%
    Check dated 2025-12-23T20:48:17.000Z thumbnail image

Stay in the know with updates to Remibrutinib Long-term Extension in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.